Literature DB >> 21145776

Investigation of effects of different treatment modalities on structural and functional vessel wall properties in patients with ankylosing spondylitis.

Erhan Capkin1, Abdulkadir Kiris, Murat Karkucak, Ismet Durmus, Ferhat Gokmen, Aysegul Cansu, Mehmet Tosun, Ahmet Ayar.   

Abstract

AIM: Ankylosing spondylitis (AS) is a chronic systemic inflammatory disease that is associated with increased cardiovascular burden. The aim of this study was to investigate vascular structural and functional changes in patients with AS, with special emphasis on the effects of different treatment modalities, through evaluation of level of vascular stiffness (pulse wave velocity [PVW]) and carotid intima media thickness (IMT-C).
METHODS: A total of 67 AS patients, and age, sex, body mass index (BMI) smoking status, lipid profiles and blood pressure-matched healthy control subjects (n=34) were studied. Of these, 34 patients were on anti-TNF alpha and 33 on non steroid anti inflammatory drugs (NSAIDs). The IMT-C and PWV values of the right common carotid artery were measured by high-resolution ultrasound.
RESULTS: The AS patients (n=67) had significantly higher PWV values than the controls [9.0 ± 1.49 m/sec vs. 8.27 ± 0.90 m/sec, P=0.004; 95% confidence interval (CI), -1.22 to -0.24]. Multiple stepwise linear regression analysis revealed that PWV could only be explained by systolic blood pressure (P<0.05) and IMT (P<0.05) in AS. Even though IMT-C in anti-TNF alpha treated group was higher compared to the NSAID treated group, it was not statistically significant (P=0.5).
CONCLUSION: PWV was found to be higher in AS patients than in the control group, and there was no significant difference between the average PWV values of AS patients treated with anti -TNF alpha or NSAIDs.
Copyright © 2010 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21145776     DOI: 10.1016/j.jbspin.2010.09.023

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  8 in total

Review 1.  Doppler US in rheumatic diseases with special emphasis on rheumatoid arthritis and spondyloarthritis.

Authors:  Hüseyin Toprak; Erkan Kılıç; Aslı Serter; Ercan Kocakoç; Salih Özgöçmen
Journal:  Diagn Interv Radiol       Date:  2014 Jan-Feb       Impact factor: 2.630

2.  Anti-TNF-α therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients.

Authors:  Fernanda Genre; Raquel López-Mejías; José A Miranda-Filloy; Begoña Ubilla; Verónica Mijares; Beatriz Carnero-López; Inés Gómez-Acebo; Trinidad Dierssen-Sotos; Sara Remuzgo-Martínez; Ricardo Blanco; Trinitario Pina; Carlos González-Juanatey; Javier Llorca; Miguel A González-Gay
Journal:  Rheumatol Int       Date:  2015-07-05       Impact factor: 2.631

Review 3.  Do anti-tumour necrosis factor-α biologics affect subclinical measures of atherosclerosis and arteriosclerosis? A systematic review.

Authors:  Laurence Knowles; Nida Nadeem; Philip J Chowienczyk
Journal:  Br J Clin Pharmacol       Date:  2020-03-08       Impact factor: 4.335

4.  Relationship of serum osteoprotegerin with arterial stiffness, preclinical atherosclerosis, and disease activity in patients with ankylosing spondylitis.

Authors:  Münevver Serdaroğlu Beyazal; Turan Erdoğan; Aysegül Kücükali Türkyılmaz; Gül Devrimsel; Medine Cumhur Cüre; Mehmet Beyazal; Ismail Sahin
Journal:  Clin Rheumatol       Date:  2016-02-04       Impact factor: 2.980

5.  Low body mass index and blood loss in primary total hip arthroplasty: results from 236 consecutive ankylosing spondylitis patients.

Authors:  Jinzhu Zhao; Jia Li; Wei Zheng; Denghui Liu; Xiaofeng Sun; Weidong Xu
Journal:  Biomed Res Int       Date:  2014-05-14       Impact factor: 3.411

Review 6.  Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases.

Authors:  Aikaterini Arida; Athanasios D Protogerou; George D Kitas; Petros P Sfikakis
Journal:  Int J Mol Sci       Date:  2018-06-27       Impact factor: 5.923

7.  Assessment of subclinical atherosclerotic cardiovascular disease in patients with ankylosing spondylitis.

Authors:  Erdinç Hatipsoylu; İlker Şengül; Taciser Kaya; Altınay Göksel Karatepe; Seniz Akçay; Leyla Isayeva; Giray Bozkaya; Erhan Tatar
Journal:  Anatol J Cardiol       Date:  2019-09       Impact factor: 1.596

8.  Infliximab therapy provides beneficial effects for choroidal thickness increase in patients with active ankylosing spondylitis: A possible mechanism mediating the suppressing of uveitis attacks.

Authors:  Murat Karkucak; Mehmet Kola; Ahmet Kalkişim; Erhan Çapkin; Ahmet Ayar; Adem Türk
Journal:  Arch Rheumatol       Date:  2020-09-04       Impact factor: 1.472

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.